nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A cell-based high-throughput screen identifies drugs that cause bleeding disorders by off-targeting the vitamin K cycle
|
Chen, Xuejie |
|
|
136 |
7 |
p. 898-908 |
artikel |
2 |
Cereblon harnesses Myc-dependent bioenergetics and activity of CD8+ T lymphocytes
|
Hesterberg, Rebecca S. |
|
|
136 |
7 |
p. 857-870 |
artikel |
3 |
Decoding hematopoietic stem cells' birth
|
Lacaud, Georges |
|
|
136 |
7 |
p. 775-776 |
artikel |
4 |
Developmental trajectory of prehematopoietic stem cell formation from endothelium
|
Zhu, Qin |
|
|
136 |
7 |
p. 845-856 |
artikel |
5 |
Does time from diagnosis to treatment affect the prognosis of patients with newly diagnosed acute myeloid leukemia?
|
Röllig, Christoph |
|
|
136 |
7 |
p. 823-830 |
artikel |
6 |
Editorial Board
|
|
|
|
136 |
7 |
p. i |
artikel |
7 |
How I treat anemia in heart failure
|
Anand, Inder |
|
|
136 |
7 |
p. 790-800 |
artikel |
8 |
How I treat anemia in the perisurgical setting
|
Shander, Aryeh |
|
|
136 |
7 |
p. 814-822 |
artikel |
9 |
How I treat cancer-associated anemia
|
Gilreath, Jeffrey A. |
|
|
136 |
7 |
p. 801-813 |
artikel |
10 |
How I treat renal anemia
|
Fishbane, Steven |
|
|
136 |
7 |
p. 783-789 |
artikel |
11 |
Introduction to a How I Treat series on anemia
|
Cazzola, Mario |
|
|
136 |
7 |
p. 773-774 |
artikel |
12 |
Leukoerythroblastosis and plasmacytoid lymphocytes in a child with SARS-CoV-2–associated multisystem inflammatory syndrome
|
Lee, Won Sok |
|
|
136 |
7 |
p. 914 |
artikel |
13 |
Multispecies RNA tomography reveals regulators of hematopoietic stem cell birth in the embryonic aorta
|
Yvernogeau, Laurent |
|
|
136 |
7 |
p. 831-844 |
artikel |
14 |
Phase 1 study of lenzilumab, a recombinant anti–human GM-CSF antibody, for chronic myelomonocytic leukemia
|
Patnaik, Mrinal M. |
|
|
136 |
7 |
p. 909-913 |
artikel |
15 |
Ritonavir- and lopinavir-induced eryptosis in a SARS-CoV-2–infected patient
|
Stalder, Gregoire |
|
|
136 |
7 |
p. 915 |
artikel |
16 |
Targeting aberrant DNA hypermethylation as a driver of ATL leukemogenesis by using the new oral demethylating agent OR-2100
|
Watanabe, Tatsuro |
|
|
136 |
7 |
p. 871-884 |
artikel |
17 |
Titans awake: HMAs for virus-driven ATL
|
Jolly, Christopher J. |
|
|
136 |
7 |
p. 777-779 |
artikel |
18 |
Treg sensitivity to FasL and relative IL-2 deprivation drive idiopathic aplastic anemia immune dysfunction
|
Lim, Shok Ping |
|
|
136 |
7 |
p. 885-897 |
artikel |
19 |
Vitamin K therapy to reduce bleeding
|
Bos, Mettine H.A. |
|
|
136 |
7 |
p. 780-782 |
artikel |
20 |
Why do Tregs suddenly disappear in aplastic anemia?
|
Scheinberg, Phillip |
|
|
136 |
7 |
p. 779-780 |
artikel |